EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions

Paolo Vercellini iD, Veronica Bandini iD, Paola Viganò iD, Deborah Ambruoso iD, Giulia Emily Cetera iD, Edgardo Somigliana iD

Human Reproduction · 05.01.2024 · 39 (1) · 18-34

DOI: 10.1093/humrep/dead206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 10.11.2023. Verfasst von Paolo Vercellini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences and Community Health, Academic Centre for Research on Adenomyosis and Endometriosis, Università degli Studi, Milano, …. Hauptthemen laut MEDLINE: Endometriosis, Adenomyosis, Chronic Pain. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Current Research IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Italian Ministry of Health, Current Research IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to consistent epidemiological data, the slope of the incidence curve of endometriosis rises rapidly and sharply around the age of 25 years. The delay in diagnosis is generally reported to be between 5 and 8 years in adult women, but it appears to be over 10 years in adolescents. If this is true, the actual onset of endometriosis in many young women would be chronologically placed in the early postmenarchal years. Ovulation and menstruation are inflammatory events that, when occurring repeatedly for years, may theoretically favour the early development of endometriosis and adenomyosis. Moreover, repeated acute dysmenorrhoea episodes after menarche may not only be an indicator of ensuing endometriosis or adenomyosis, but may also promote the transition from acute to chronic pelvic pain through central sensitization mechanisms, as well as the onset of chronic overlapping pain conditions. Therefore, secondary prevention aimed at reducing suffering, limiting lesion progression, and preserving future reproductive potential should be focused on the age group that could benefit most from the intervention, i.e. severely symptomatic adolescents. Early-onset endometriosis and adenomyosis should be promptly suspected even when physical and ultrasound findings are negative, and long-term ovulatory suppression may be established until conception seeking. As nowadays this could mean using hormonal therapies for several years, drug safety evaluation is crucial. In adolescents without recognized major contraindications to oestrogens, the use of very low-dose combined oral contraceptives is associated with a marginal increase in the individual absolute risk of thromboembolic events. Oral contraceptives containing oestradiol instead of ethinyl oestradiol may further limit such risk. Oral, subcutaneous, and intramuscular progestogens do not increase the thromboembolic risk, but may interfere with attainment of peak bone mass in young women. Levonorgestrel-releasing intra-uterine devices may be a safe alternative for adolescents, as amenorrhoea is frequently induced without suppression of the ovarian activity. With regard to oncological risk, the net effect of long-term oestrogen–progestogen combinations use is a small reduction in overall cancer risk. Whether surgery should be considered the first-line approach in young women with chronic pelvic pain symptoms seems questionable. Especially when large endometriomas or infiltrating lesions are not detected at pelvic imaging, laparoscopy should be reserved to adolescents who refuse hormonal treatments or in whom first-line medications are not effective, not tolerated, or contraindicated. Diagnostic and therapeutic algorithms, including self-reported outcome measures, for young individuals with a clinical suspicion of early-onset endometriosis or adenomyosis are proposed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisAdenomyosisChronic PainAdultAdolescentFemaleHumansSecondary PreventionDysmenorrheaPelvic PainContraceptives, OralChronic Disease

Stichwörter der Autor:innen

adenomyosiscentral sensitizationchronic pelvic painendometriosislaparoscopymenstruationoral contraceptivesovulationprogestogens

Substanzen

Contraceptives, Oral

Autor:innen und Institutionen

  • Department of Clinical Sciences and Community Health, Academic Centre for Research on Adenomyosis and Endometriosis, Università degli Studi, Milano, Italy.
  • Gynecology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

ORCID-Profile: Paolo Vercellini, Veronica Bandini, Paola Viganò, Deborah Ambruoso, Giulia Emily Cetera, Edgardo Somigliana

Förderung

  • Current Research IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
  • Italian Ministry of Health, Current Research IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano

Zitieren

APA

Vercellini, P., Bandini, V., Viganò, P., Ambruoso, D., Cetera, G. E., & Somigliana, E. (2024). Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions. Human Reproduction, 39(1), 18-34. https://doi.org/10.1093/humrep/dead206

Vancouver

Vercellini P, Bandini V, Viganò P, Ambruoso D, Cetera GE, Somigliana E. Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions. Human Reproduction. 2024;39(1):18-34. doi:10.1093/humrep/dead206

BibTeX
@article{Vercellini2024,
  author = {Vercellini, Paolo and Bandini, Veronica and Viganò, Paola and Ambruoso, Deborah and Cetera, Giulia Emily and Somigliana, Edgardo},
  title = {Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions},
  journal = {Human Reproduction},
  year = {2024},
  volume = {39},
  number = {1},
  pages = {18--34},
  doi = {10.1093/humrep/dead206}
}
Kostenlos starten →